Depletion or inhibition of Mcl‐1 was observed to resensitize the BC cells to BETi‐induced apoptosis, which is indicative of the use of targeting Mcl‐1 to plausibly address the BETi resistance caused by the lowered FBW7 expression in BC. The gene discussed is MCL1; the disease is breast cancer.